World Vaccine & Immunotherapy Congress
December 2-5, 2019
San Francisco, CA
Stop by to talk to us about your vaccine or immunotherapy development to learn how we can move your program forward to in vivo studies and clinical use. IITRI has over 15 years of experience in vaccine development, GLP vaccine toxicology, and monitoring immune responses from viral and biologic therapies. We also offer BSL-2 toxicology studies in mouse tumor models and NHP immunogenicity studies.
Attending the meeting will be:
Todd Bucciarelli, MBA
Director, Business Development
Robert Baker, PhD
Division Manager, Molecular and Microbiology
Request a meeting with our staff!